These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17130356)

  • 1. Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events.
    Waxman S; Ishibashi F; Muller JE
    Circulation; 2006 Nov; 114(22):2390-411. PubMed ID: 17130356
    [No Abstract]   [Full Text] [Related]  

  • 2. Endovascular filter-assisted treatment of atheroembolization from subclavian plaque.
    Rigatelli G; Cardaioli P; Giordan M
    Cardiovasc Revasc Med; 2006; 7(4):264-5. PubMed ID: 17174878
    [No Abstract]   [Full Text] [Related]  

  • 3. Magnetic resonance angiography: current status in the planning and follow-up of endovascular treatment in lower-limb arterial disease.
    Lakshminarayan R; Simpson JO; Ettles DF
    Cardiovasc Intervent Radiol; 2009 May; 32(3):397-405. PubMed ID: 19130124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of asymptomatic arterial disease.
    Franks PJ; MacSweeney ST; Cuming R; Ellis MR; Powell JT; Greenhalgh RM
    Ann Chir Gynaecol; 1992; 81(2):115-7. PubMed ID: 1622062
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular imaging of vulnerable plaque by cardiac magnetic resonance imaging.
    Burgstahler C; Hombach V; Rasche V
    Semin Thromb Hemost; 2007 Mar; 33(2):165-72. PubMed ID: 17340465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of coronary vulnerable plaques.
    García-García HM; Gonzalo N; Granada JF; Regar E; Serruys PW
    Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):209-22. PubMed ID: 18248275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection and treatment of vulnerable plaque].
    Gaxiola E
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-178-84. PubMed ID: 18938723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Optical coherence tomography for coronary visualisation].
    Radu MD; Jørgensen E; Saunamäki K
    Ugeskr Laeger; 2009 Aug; 171(35):2466-7. PubMed ID: 19732532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic coronary angiography in patients with peripheral arterial disease: a sub-study of the Coronary Artery Revascularization Prophylaxis Trial.
    Garcia S; McFalls EO; Goldman S; Larsen GC; Littooy F; Moritz TE; Reda DJ; Ward HB; Shunk K; Hattler B
    J Interv Cardiol; 2008 Oct; 21(5):369-74. PubMed ID: 18761563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute coronary syndromes: an emphasis shift from treatment to prevention; and the enduring challenge of vulnerable plaque detection in the cardiac catheterization laboratory.
    Valgimigli M; Agostoni P; Serruys PW
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):221-9. PubMed ID: 17413297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance evaluation of the associations of thoracic and abdominal aortic plaques with the presence and extent of coronary artery stenosis.
    Ashida K; Momiyama Y; Fayad ZA; Tanaka N; Kato R; Taniguchi H; Ohmori R; Kihara T; Kameyama A; Nagata M; Nakamura H; Ohsuzu F
    J Cardiovasc Magn Reson; 2007; 9(6):855-61. PubMed ID: 18066744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulnerable plaque intervention: State of the art.
    Young JJ; Phillips HR; Marso SP; Granada JF; McPherson JA; Waksman R; Steinhubl SR; Schwartz RS; Stone GW
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):367-74. PubMed ID: 18288729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An emerging paradigm in atherosclerosis: focus on subclinical disease.
    Miller M
    Postgrad Med; 2009 Mar; 121(2):49-59. PubMed ID: 19332962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of vulnerable coronary artery plaques.
    Hamdan A; Assali A; Fuchs S; Battler A; Kornowski R
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):65-74. PubMed ID: 17585387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ["Absorbable stents: state of affairs." Interview by Wiebke Kathmann].
    Erbel R
    Dtsch Med Wochenschr; 2006 Oct; Suppl 1():23. PubMed ID: 17595813
    [No Abstract]   [Full Text] [Related]  

  • 16. High-resolution 3D contrast-enhanced MRA with parallel imaging techniques before endovascular interventional treatment of arterial stenosis.
    Lin J; Li D; Yan F
    Vasc Med; 2009 Nov; 14(4):305-11. PubMed ID: 19808715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of peripheral arterial occlusive disease with major coronary events in a mediterranean population with low coronary heart disease incidence.
    Merino J; Planas A; De Moner A; Gasol A; Contreras C; Marrugat J; Vidal-Barraquer F; Clarà A
    Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):71-6. PubMed ID: 18396072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unstable coronary plaques and cardiac events in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits: questions and quandaries.
    Shiomi M; Fan J
    Curr Opin Lipidol; 2008 Dec; 19(6):631-6. PubMed ID: 18957890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging.
    Jahnke C; Nagel E; Gebker R; Kokocinski T; Kelle S; Manka R; Fleck E; Paetsch I
    Circulation; 2007 Apr; 115(13):1769-76. PubMed ID: 17353441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening of asymptomatic coronaropathy with adenosine stress myocardial perfusion MRI: a pilot study].
    Brisbois D; Raskinet B; Djekic J; Morar A; Broussaud T; Mancini I; Magotteaux P; Nchimi A
    JBR-BTR; 2007; 90(2):92-6. PubMed ID: 17555067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.